Primary sclerosing cholangitis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients who were diagnosed as primary sclerosing cholangitis (definite or probable) with the MHLW criteria 2) Patients who gave informed consent to participate in this study
Exclusion criteria
Exclusion criteria: 1) Patients who were diagnosed as primary sclerosing cholangitis (possible) with the MHLW criteria 2) Patients who were diagnosed as IgG4-related sclerosing cholangitis or secondary sclerosing cholangitis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Death or liver transplantation | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) developmenet of cholangiocarcinoma or colorectal cancer 2) develpment of clinical events including bacterial cholangitis, jaundice 3) progression of liver fibrosis 4) EQ-5D-5L | — |
Countries
Japan
Contacts
Teikyo University School of Medicine Department of Medicine